Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L, Spirtas R, McDonald JA, Strom BL, Burkman RT, Simon MS, Liff JM, Daling JR, Malone KE.

Cancer Causes Control. 2012 May;23(5):671-81. doi: 10.1007/s10552-012-9925-x. Epub 2012 Mar 15.

2.

Polymorphisms in genes involved in the estrogen pathway and mammographic density.

Dumas I, Diorio C.

BMC Cancer. 2010 Nov 22;10:636. doi: 10.1186/1471-2407-10-636.

3.

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.

Breast Cancer Res Treat. 2010 Jan;119(2):463-74. doi: 10.1007/s10549-009-0407-0. Epub 2009 May 8. Erratum in: Breast Cancer Res Treat. 2010 Jan;119(2):475.

PMID:
19424794
4.

Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.

Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson HW, Farin FM, Thummel KE, Daling JR, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1461-7. doi: 10.1158/1055-9965.EPI-08-0917. Epub 2009 Apr 21.

5.

Variants of estrogen-related genes and breast cancer risk in European and African American women.

Quan L, Hong CC, Zirpoli G, Roberts MR, Khoury T, Sucheston-Campbell LE, Bovbjerg DH, Jandorf L, Pawlish K, Ciupak G, Davis W, Bandera EV, Ambrosone CB, Yao S.

Endocr Relat Cancer. 2014;21(6):853-64. doi: 10.1530/ERC-14-0250. Epub 2014 Sep 16.

6.

Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC.

Cancer Causes Control. 2015 Jan;26(1):121-31. doi: 10.1007/s10552-014-0491-2. Epub 2014 Nov 25.

7.

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

BMC Med Genet. 2007 Dec 1;8:72.

8.

Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women.

Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, Claeys GB, Van Dyke AL, Land SJ, Schwartz AG.

Carcinogenesis. 2009 Apr;30(4):626-35. doi: 10.1093/carcin/bgp033. Epub 2009 Jan 27.

9.

Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1751-9. doi: 10.1158/1055-9965.EPI-08-0168.

10.

Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.

Son BH, Kim MK, Yun YM, Kim HJ, Yu JH, Ko BS, Kim H, Ahn SH.

J Cancer Res Clin Oncol. 2015 Apr;141(4):633-45. doi: 10.1007/s00432-014-1849-2. Epub 2014 Oct 17.

PMID:
25323936
11.

Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort.

Ghisari M, Long M, Røge DM, Olsen J, Bonefeld-Jørgensen EC.

Environ Res. 2017 Apr;154:325-333. doi: 10.1016/j.envres.2017.01.020. Epub 2017 Feb 2.

PMID:
28157646
12.

Estrogen pathway polymorphisms and mammographic density.

Dumas I, Diorio C.

Anticancer Res. 2011 Dec;31(12):4369-86. Review.

PMID:
22199302
13.

Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.

Miyoshi Y, Noguchi S.

Biomed Pharmacother. 2003 Dec;57(10):471-81. Review.

PMID:
14637391
14.

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H.

Breast Cancer Res Treat. 2008 Mar;108(1):137-49. Epub 2007 Jun 23.

PMID:
17588204
15.

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, Li JY, Yang F, Lee H, Huang Y.

DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.

PMID:
21438753
16.

Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Liu ET, Liu J.

PLoS Genet. 2010 Jul 1;6(7):e1001012. doi: 10.1371/journal.pgen.1001012.

17.

Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.

Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Sherman ME, Sutter TR, Garcia-Closas M.

Pharmacogenet Genomics. 2006 Aug;16(8):547-53.

PMID:
16847423
18.

Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.

Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T.

Int J Cancer. 2009 Aug 15;125(4):837-43. doi: 10.1002/ijc.24434.

19.

Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers.

Hamaguchi M, Nishio M, Toyama T, Sugiura H, Kondo N, Fujii Y, Yamashita H.

Jpn J Clin Oncol. 2008 Nov;38(11):734-42. doi: 10.1093/jjco/hyn097. Epub 2008 Sep 26.

PMID:
18820009
20.

African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.

Kato I, Cichon M, Yee CL, Land S, Korczak JF.

Cancer Epidemiol. 2009 Jul;33(1):24-30. doi: 10.1016/j.canep.2009.04.009. Epub 2009 May 14.

Supplemental Content

Support Center